Editorial overview: Energy biotechnology as an integral solution to global challenges
Curr Opin Biotechnol. 2023 Oct 2;84:103006. doi: 10.1016/j.copbio.2023.103006. Online ahead of print.NO ABSTRACTPMID:37793238 | DOI:10.1016/j.copbio.2023.103006 (Source: JOP)
Source: JOP - October 4, 2023 Category: Gastroenterology Authors: Junyoung O Park David R Nielsen Source Type: research
Editorial overview: Energy biotechnology as an integral solution to global challenges
Curr Opin Biotechnol. 2023 Oct 2;84:103006. doi: 10.1016/j.copbio.2023.103006. Online ahead of print.NO ABSTRACTPMID:37793238 | DOI:10.1016/j.copbio.2023.103006 (Source: JOP)
Source: JOP - October 4, 2023 Category: Gastroenterology Authors: Junyoung O Park David R Nielsen Source Type: research
Editorial overview: Energy biotechnology as an integral solution to global challenges
Curr Opin Biotechnol. 2023 Oct 2;84:103006. doi: 10.1016/j.copbio.2023.103006. Online ahead of print.NO ABSTRACTPMID:37793238 | DOI:10.1016/j.copbio.2023.103006 (Source: JOP)
Source: JOP - October 4, 2023 Category: Gastroenterology Authors: Junyoung O Park David R Nielsen Source Type: research
Editorial overview: Energy biotechnology as an integral solution to global challenges
Curr Opin Biotechnol. 2023 Oct 2;84:103006. doi: 10.1016/j.copbio.2023.103006. Online ahead of print.NO ABSTRACTPMID:37793238 | DOI:10.1016/j.copbio.2023.103006 (Source: JOP)
Source: JOP - October 4, 2023 Category: Gastroenterology Authors: Junyoung O Park David R Nielsen Source Type: research
Editorial overview: Energy biotechnology as an integral solution to global challenges
Curr Opin Biotechnol. 2023 Oct 2;84:103006. doi: 10.1016/j.copbio.2023.103006. Online ahead of print.NO ABSTRACTPMID:37793238 | DOI:10.1016/j.copbio.2023.103006 (Source: JOP)
Source: JOP - October 4, 2023 Category: Gastroenterology Authors: Junyoung O Park David R Nielsen Source Type: research
Editorial overview: Energy biotechnology as an integral solution to global challenges
Curr Opin Biotechnol. 2023 Oct 2;84:103006. doi: 10.1016/j.copbio.2023.103006. Online ahead of print.NO ABSTRACTPMID:37793238 | DOI:10.1016/j.copbio.2023.103006 (Source: JOP)
Source: JOP - October 4, 2023 Category: Gastroenterology Authors: Junyoung O Park David R Nielsen Source Type: research
Editorial overview: Energy biotechnology as an integral solution to global challenges
Curr Opin Biotechnol. 2023 Oct 2;84:103006. doi: 10.1016/j.copbio.2023.103006. Online ahead of print.NO ABSTRACTPMID:37793238 | DOI:10.1016/j.copbio.2023.103006 (Source: JOP)
Source: JOP - October 4, 2023 Category: Gastroenterology Authors: Junyoung O Park David R Nielsen Source Type: research
Editorial overview: Energy biotechnology as an integral solution to global challenges
Curr Opin Biotechnol. 2023 Oct 2;84:103006. doi: 10.1016/j.copbio.2023.103006. Online ahead of print.NO ABSTRACTPMID:37793238 | DOI:10.1016/j.copbio.2023.103006 (Source: JOP)
Source: JOP - October 4, 2023 Category: Gastroenterology Authors: Junyoung O Park David R Nielsen Source Type: research
Editorial overview: Energy biotechnology as an integral solution to global challenges
Curr Opin Biotechnol. 2023 Oct 2;84:103006. doi: 10.1016/j.copbio.2023.103006. Online ahead of print.NO ABSTRACTPMID:37793238 | DOI:10.1016/j.copbio.2023.103006 (Source: JOP)
Source: JOP - October 4, 2023 Category: Gastroenterology Authors: Junyoung O Park David R Nielsen Source Type: research
Editorial overview: Energy biotechnology as an integral solution to global challenges
Curr Opin Biotechnol. 2023 Oct 2;84:103006. doi: 10.1016/j.copbio.2023.103006. Online ahead of print.NO ABSTRACTPMID:37793238 | DOI:10.1016/j.copbio.2023.103006 (Source: JOP)
Source: JOP - October 4, 2023 Category: Gastroenterology Authors: Junyoung O Park David R Nielsen Source Type: research
Editorial overview: Energy biotechnology as an integral solution to global challenges
Curr Opin Biotechnol. 2023 Oct 2;84:103006. doi: 10.1016/j.copbio.2023.103006. Online ahead of print.NO ABSTRACTPMID:37793238 | DOI:10.1016/j.copbio.2023.103006 (Source: JOP)
Source: JOP - October 4, 2023 Category: Gastroenterology Authors: Junyoung O Park David R Nielsen Source Type: research
Editorial overview: Energy biotechnology as an integral solution to global challenges
Curr Opin Biotechnol. 2023 Oct 2;84:103006. doi: 10.1016/j.copbio.2023.103006. Online ahead of print.NO ABSTRACTPMID:37793238 | DOI:10.1016/j.copbio.2023.103006 (Source: JOP)
Source: JOP - October 4, 2023 Category: Gastroenterology Authors: Junyoung O Park David R Nielsen Source Type: research
Cenobamate and Clobazam Combination as Personalized Medicine in Autoimmune-Associated Epilepsy With Anti-Gad65 Antibodies
DISCUSSION: Treatment with the combination CNB + CLB could be a type of personalized medicine in patients with AAE with anti-GAD65. Our preliminary data will need to be endorsed with new prospective and controlled studies.PMID:37607753 | PMC:PMC10443460 | DOI:10.1212/NXI.0000000000200151 (Source: JOP)
Source: JOP - August 22, 2023 Category: Gastroenterology Authors: Pedro J Serrano-Castro Juan J Rodr íguez-Uranga Pablo Cabezudo-Garc ía Guillermina Garc ía-Martín Jorge Romero-Godoy Guillermo Estivill-Torr ús Nicol ás Lundahl Ciano-Petersen Bego ña Oliver Jes ús Ortega-Pinazo Yolanda L ópez-Moreno Maria J Agui Source Type: research
Cenobamate and Clobazam Combination as Personalized Medicine in Autoimmune-Associated Epilepsy With Anti-Gad65 Antibodies
DISCUSSION: Treatment with the combination CNB + CLB could be a type of personalized medicine in patients with AAE with anti-GAD65. Our preliminary data will need to be endorsed with new prospective and controlled studies.PMID:37607753 | PMC:PMC10443460 | DOI:10.1212/NXI.0000000000200151 (Source: JOP)
Source: JOP - August 22, 2023 Category: Gastroenterology Authors: Pedro J Serrano-Castro Juan J Rodr íguez-Uranga Pablo Cabezudo-Garc ía Guillermina Garc ía-Martín Jorge Romero-Godoy Guillermo Estivill-Torr ús Nicol ás Lundahl Ciano-Petersen Bego ña Oliver Jes ús Ortega-Pinazo Yolanda L ópez-Moreno Maria J Agui Source Type: research
Cenobamate and Clobazam Combination as Personalized Medicine in Autoimmune-Associated Epilepsy With Anti-Gad65 Antibodies
DISCUSSION: Treatment with the combination CNB + CLB could be a type of personalized medicine in patients with AAE with anti-GAD65. Our preliminary data will need to be endorsed with new prospective and controlled studies.PMID:37607753 | PMC:PMC10443460 | DOI:10.1212/NXI.0000000000200151 (Source: JOP)
Source: JOP - August 22, 2023 Category: Gastroenterology Authors: Pedro J Serrano-Castro Juan J Rodr íguez-Uranga Pablo Cabezudo-Garc ía Guillermina Garc ía-Martín Jorge Romero-Godoy Guillermo Estivill-Torr ús Nicol ás Lundahl Ciano-Petersen Bego ña Oliver Jes ús Ortega-Pinazo Yolanda L ópez-Moreno Maria J Agui Source Type: research
